- Home
- NVNI vs ICCC Comparison
NVNI vs ICCC Comparison
Compare NVNI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- ICCC
- Stock Information
- Founded
- NVNI 2019
- ICCC 1982
- Country
- NVNI Brazil
- ICCC United States
- Employees
- NVNI N/A
- ICCC N/A
- Industry
- NVNI
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- ICCC Health Care
- Exchange
- NVNI Nasdaq
- ICCC Nasdaq
- Market Cap
- NVNI 57.2M
- ICCC 57.4M
- IPO Year
- NVNI N/A
- ICCC 1987
- Fundamental
- Price
- NVNI $4.13
- ICCC $6.06
- Analyst Decision
- NVNI
- ICCC
- Analyst Count
- NVNI 0
- ICCC 0
- Target Price
- NVNI N/A
- ICCC N/A
- AVG Volume (30 Days)
- NVNI 1.3M
- ICCC 22.4K
- Earning Date
- NVNI 09-30-2025
- ICCC 11-12-2025
- Dividend Yield
- NVNI N/A
- ICCC N/A
- EPS Growth
- NVNI N/A
- ICCC N/A
- EPS
- NVNI N/A
- ICCC 0.20
- Revenue
- NVNI $31,250,627.00
- ICCC $28,274,756.00
- Revenue This Year
- NVNI $12.05
- ICCC N/A
- Revenue Next Year
- NVNI $15.02
- ICCC N/A
- P/E Ratio
- NVNI N/A
- ICCC $30.20
- Revenue Growth
- NVNI 1491.58
- ICCC 21.75
- 52 Week Low
- NVNI $1.44
- ICCC $3.38
- 52 Week High
- NVNI $121.90
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- NVNI 71.42
- ICCC 41.50
- Support Level
- NVNI $2.96
- ICCC $6.19
- Resistance Level
- NVNI $4.94
- ICCC $6.99
- Average True Range (ATR)
- NVNI 0.51
- ICCC 0.38
- MACD
- NVNI 0.21
- ICCC -0.03
- Stochastic Oscillator
- NVNI 83.44
- ICCC 6.06
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.